TUDOR INVESTMENT CORP ET AL
Position in COLL — Collegium Pharmaceutical, Inc
CIK 923093
STAMFORD, CT
Position in COLL
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$461,524
-$333,724 QoQ
Shares Held
13,956
-18.7% QoQ
Ownership
0.043%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Sep 2025
3 quarters on record
Voting authority
Sole 50.ToString("F0")%
Shared 50.ToString("F0")%
None 0.ToString("F0")%
Common Shares in COLL Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Mar 31, 2026TUDOR INVESTMENT CORP ET AL holds $23,421,840 across 9 Drug Manufacturers - Specialty & Generic names. COLL ranks #5 (2.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | TEVA |
Teva Pharmaceutical Industries Ltd
|
544,501 | $16,400,370 | |
| 2 | VTRS |
Viatris Inc
|
276,210 | $3,731,597 | |
| 3 | LQDA |
Liquidia Corp
|
40,263 | $1,519,525 | |
| 4 | XERS |
Xeris Biopharma Holdings, Inc.
|
107,414 | $623,001 | |
| 5 | COLL |
Collegium Pharmaceutical, Inc
This page
|
13,956 | $461,524 | |
| 6 | AMLX |
Amylyx Pharmaceuticals, Inc.
|
31,334 | $435,542 | |
| 7 | ORGO |
Organogenesis Holdings Inc.
|
63,580 | $150,684 | |
| 8 | BHC |
Bausch Health Companies Inc.
|
11,800 | $63,720 |
All Filings in COLL
Export CSV
3 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $461,524 | 13,956 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $795,248 | 17,176 | Shares | Defined | 2026-02-17 | |
| 2025-09-30 | $560,189 | 16,010 | Shares | Defined | 2025-11-14 | |
| No filing history on record for this holder in this stock. | ||||||